Search Ontology:
ChEBI
PF-3758309
- Term ID
- CHEBI:93751
- Synonyms
-
- N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methylthieno[3,2-d]pyrimidin-4-yl)amino]-4,6-dihydropyrrolo[3,4-c]pyrazole-5(1H)-carboxamide
- PF 309
- PF 3758309
- PF-03758309
- PF-309
- PF309
- PF3758309
- Definition
- A member of the class of thienopyrimidines that is thieno[3,2-d]pyrimidine substituted by methyl and (5-{[(1S)-2-(dimethylamino)-1-phenylethyl]carbamoyl}-6,6-dimethyl-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazol-3-yl)amino groups at positions 2 and 4, respectively. It is a potent inhibitor of PAK4 and inhibits the growth of multiple human tumor xenografts.
- References
-
- cas:898044-15-0
- drugbank:DB11775
- lincs.smallmolecule:LSM-4254
- pdb-ccd:7KC
- pubmed:20439741
- pubmed:23524533
- pubmed:23543898
- pubmed:24204982
- pubmed:24366569
- pubmed:24432870
- pubmed:25640698
- pubmed:29048629
- pubmed:29191878
- pubmed:30455231
- pubmed:31312349
- pubmed:31595158
- pubmed:32469945
- pubmed:32829006
- pubmed:33414491
- pubmed:33987822
- pubmed:35401439
- pubmed:35939342
- pubmed:36240067
- pubmed:36671485
- pubmed:37258566
- pubmed:37564209
- pubmed:37568037
- pubmed:37864885
- pubmed:38336988
- pubmed:38885414
- Ontology
- ChEBI ( EBI )
Phenotype
Phenotype resulting from PF-3758309
Phenotype where environments contain PF-3758309
Phenotype modified by environments containing PF-3758309
Phenotype affecting PF-3758309
Human Disease Model